IBDR Quarterly Clinical Report, Spring 2024
Public/National Edition – Our special thank you to all contributors to the Registry over the years
From 2019 to 2024, we have provided over 900 quarterly clinical reports to IBD teams that have submitted data to us. These reports provide important measurements of IBD treatments and care, and showcases our approach to facilitating data-driven insights and health quality improvement. To thank everyone who has contributed to the IBD Registry, and to return outputs to IBD patients, IBD communities and the public, we are proud to present a publicly available “National” edition of our Spring 2024 report.
View and Download (.pdf)
FAQs about this report
Usage Rights and Licensing
Quarterly Clinical Report Spring 2024 (National) by IBD Registry is licensed under CC BY-ND 4.0
This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use. CC BY-ND includes the following elements:
BY: credit must be given to the creator.
ND: No derivatives or adaptations of the work are permitted.
Please cite us using:
“This analysis was published by the IBD Registry in March 2024, licensed under CC BY-NC-ND 4.0. More information about how the IBD Registry collects and analyses data can be found at ibdregistry.org.uk”
Who can I contact for more information or questions or feedback?
The registry has reduced staffing from 1 April 2024. During Spring 2024 please contact [email protected]